A Study to Assess the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine
Clinical trial NCT02606084 · COMPLETED
Trial details
- NCT number
- NCT02606084
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-04
- Primary completion
- 2018-02-02
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.